How to Prepare Performance Verification Documentation for Overseas Registration of Sterilization and Disinfection Equipment

Performance verification documentation is a core component of the technical file for overseas registration of sterilization and disinfection equipment and is also the area most likely to receive requests for supplementary information. The first step is not to rush into testing but to confirm whether the target country regulates the device as a medical device and, if so, its risk classification. Companies should adopt the GHWP mutual recognition approach, first assess whether existing test reports and data under NMPA, CE, FDA, or ISO 13485 can be reused, and then supplement with the necessary local documents. Common risks include lack of understanding of mandatory local agent or authorized representative requirements, inconsistency between performance verification standards and the target country, lack of biocompatibility or chemical residue data, failure to consider the stability of disinfection effectiveness, and neglecting post-market surveillance and change reporting obligations. It is advised to conduct a regulatory gap analysis first, establish a core technical file library, and then perform local adaptation for the target market to reduce duplicate testing and additional information requests.

Published: September 1, 2026 | Updated: September 1, 2026

Executive Summary

• Confirm whether the target country regulates the device as a medical device and determine its risk classification.
• Assess reusability of existing NMPA, CE, FDA, and ISO 13485 data before starting new tests.
• Standardize performance verification protocols according to target market standards and requirements.
• Address common pitfalls such as missing biocompatibility data, inconsistent standards, and unauthorized representative oversight.
• Use a core technical file library plus country-specific add-on packages to streamline multi-country registration.

Applicable Scenarios and Core Questions

Sterilization and disinfection equipment covers a wide range, including steam sterilizers, ethylene oxide sterilizers, hydrogen peroxide low-temperature plasma sterilizers, ultraviolet disinfection devices, ozone disinfection devices, washer-disinfectors, and more. These products differ in purpose, working principle, and how they contact the human body, so the required performance verification documentation for overseas registration will also vary.

Companies must first ask: Is this product a medical device in the regulatory sense of the target country? Many sterilization and disinfection devices are classified as medical devices in some countries but may fall into other regulatory categories elsewhere, such as personal protective equipment, biocides, or general electrical products. This determination directly affects the registration pathway and documentation requirements.

The core issue is not "creating a performance verification report" but "how to make the target country's regulatory agency accept that your product is safe and effective." Therefore, before preparing documentation, you must clarify the target market's regulatory requirements and review logic; otherwise, testing may be performed but fail to meet local standards.

Registration Decision Logic

Step one is to determine the regulatory scope. Under the EU MDR, for example, most sterilization and disinfection equipment falls into Class IIa or IIb, requiring the involvement of a notified body. In the United States, some sterilizers may be Class II and require a 510(k) submission. In GHWP member countries across Southeast Asia, the Middle East, and Latin America, classification logic varies, so companies cannot simply rely on domestic classification.

Step two is to confirm the applicant entity. Most overseas markets require applications to be submitted by a local registrant, importer, or authorized representative. Companies need to appoint a qualified local agent in advance. This agent is not only responsible for submission but also for post-market contact, adverse event reporting, and certificate maintenance.

Step three is to assess the reusability of existing documentation. If the company already has NMPA registration certificates, CE certificates, or FDA 510(k) files, much of the technical data can be integrated into overseas registration files, but differences in standard versions, test methods, and language requirements must be noted.

Step four is to confirm the depth of performance verification. For sterilization equipment, in particular, data on sterilization effectiveness, chemical compatibility, material compatibility, biological indicator results, residual toxicity, and temperature/humidity distribution validation are required. These data cannot simply cite similar products but must come from the actual product.

Documentation and Evidence

The core of the performance verification file is a performance study report, which typically includes equipment technical parameters, operating conditions, performance indicators, and test results. Companies should provide a clear product description and intended use statement, and explain why the performance indicators support the intended sterilization or disinfection effect.

International standards are the most important source of evidence. ISO 11135 applies to ethylene oxide sterilization, ISO 17665 to moist heat sterilization, ISO 14937 to general sterilizing agents, and the IEC 61010 series to electrical safety. Companies need to confirm which standards are adopted by the target country and design validation protocols accordingly.

Beyond sterilization effectiveness, many regulators also focus on chemical and biological risks, such as ethylene oxide residues, hydrogen peroxide residue levels, extractable toxicity, and surface biocompatibility. This data often needs to be generated by qualified laboratories, and the reports must comply with local requirements.

Risk management documentation also supports performance verification. The ISO 14971 risk management report should cross-reference the performance verification data to demonstrate consistency between risk control measures and verification conclusions.

In addition, labels and instructions for use must be consistent with the performance verification results. Parameters listed on the device, such as temperature, time, load capacity, and environmental requirements, must be supported by experimental data; otherwise, they may be considered false claims.

Common Mistakes

• Directly applying domestic registration reports without checking whether the test standards used by the target country are consistent.
• Neglecting the mandatory requirements for local agents and authorized representatives, resulting in rejected submissions or review delays.
• Only performing sterilization effectiveness validation and lacking chemical residue, toxicological, or biocompatibility data.
• Using performance verification data from prototype units not produced under an ISO 13485 quality management system, which does not meet system requirements.
• Failing to consider the impact of transportation, storage, and use environment on sterilization performance, so validation conditions do not reflect real-world use.
• Inconsistency between performance parameters on labels and instructions and the verification report, leading to regulatory questions.
• Omitting post-market surveillance plans, adverse event reporting, or periodic update submissions.
• Duplicating translation and testing for multi-country registrations instead of establishing a core technical file library.

Company Preparation Checklist

• Confirm the target country's regulatory classification and risk class, and document the assessment in writing.
• Appoint a local authorized representative or agent and clearly define responsibilities and data exchange processes.
• Review existing performance verification data under NMPA, CE, FDA, ISO 13485, MDSAP, and other systems.
• Develop performance verification protocols based on target market standards, including sterilization effectiveness, stability, and safety indicators.
• Collect and organize complete product technical documentation, including drawings, BOM, software versions, and key component information.
• Commission ISO/IEC 17025 accredited laboratories to issue test reports that can be recognized by the target country.
• Prepare an ISO 14971 compliant risk management report and cross-reference it with performance verification data.
• Complete local adaptation of labels, instructions, and packaging to ensure parameters and warnings match the verification data.
• Develop a post-market surveillance plan and adverse event reporting process, implemented through the local agent.
• Create a multi-country registration document mapping table, indicating common data and local differences for each market.

AIMEILI Regulatory Interpretation and Business Impact

The most common misjudgment is underestimating the "localization" nature of performance verification. Many companies believe that tests performed in Europe can be directly used for Southeast Asia or the Middle East, but in practice, different markets have differences in technical requirements and acceptance of pre-clinical evidence for sterilization validation reports. We recommend conducting a regulatory gap analysis before project initiation rather than waiting until after submission to discover missing critical data.

In the early project phase, determine the market priority and registration pathway first, then reverse-engineer the performance verification requirements based on the target country list. This approach avoids full testing for a single small market and also prevents one market's requirements from overturning the core technical solution.

Reusable documentation includes product design verification reports, basic safety and electromagnetic compatibility test reports, ISO 13485 certificates, and general sterilization effectiveness study data. Documentation that must be localized includes language translation, additional tests required by local regulations, authorized representative documents, explanations of local clinical use scenarios, and label warning information.

Local agency and certificate control are critical. Many companies' overseas registration certificates are held by the local agent, and if the agent becomes uncooperative, the certificate becomes an invalid asset. We recommend clarifying the processes for change applications, renewals, and certificate transfers in the agreement, and retaining all original technical files.

For multi-country registration, a "core file package + country-specific add-on package" structure is recommended. Use the common technical documentation as the core, then add country-specific risk analyses, authorization documents, and local declarations for each country. This significantly reduces the risk of rework and additional information requests and accelerates access to new markets.

Business Impact: Proper preparation of performance verification documentation reduces approval delays, lowers the cost of duplicate testing, and supports faster market access across GHWP member states. A well-structured core technical file library enables companies to extend into new markets efficiently and protects the value of regulatory certificates by maintaining control over the documentation.

Frequently Asked Questions

Q: Does the performance verification report for sterilization and disinfection equipment have to be issued by a local laboratory?

A: Not necessarily. Most GHWP member countries accept reports from third-party laboratories that comply with international standards or hold appropriate qualifications. However, some countries may require the laboratory to have locally recognized accreditation or the report to be notarized. Companies should confirm the acceptable laboratory scope with the local agent or regulatory agency in advance to avoid requests for additional information due to unrecognized laboratories.

Q: Can we apply for overseas registration if we do not have a Chinese registration certificate for the sterilization equipment?

A: Yes, but the difficulty will increase. Regulatory agencies generally focus on the technical file and verification data of the product itself, not on whether a home-country registration certificate exists. Companies must provide complete performance verification, risk management, and quality system documentation, and may also need to provide clinical evaluation or usage evidence.

Q: How should the software component of sterilization and disinfection equipment be verified?

A: If the device includes software used for controlling sterilization cycles, recording data, or generating alarms, software verification documentation is required. This generally includes software requirements specifications, architecture design, verification test records, and cybersecurity assessment. The higher the software safety class, the more rigorous the verification evidence required.

Content Review and Applicability

Author: AIMEILI Regulatory Editorial Department; Professional review: AIMEILI Medical Device International Registration Project Team. Sources: Priority is given to official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used as supplementary reference. This article is intended for preliminary understanding, documentation preparation, and project planning, and does not replace the official requirements, testing conclusions, or legal advice of the target country's regulatory agency.